Article info
PDFReview
Topical carbonic anhydrase inhibitors and glaucoma in 2021: where do we stand?
- Correspondence to Professor Alon Harris, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; palonharris{at}gmail.com
Citation
Topical carbonic anhydrase inhibitors and glaucoma in 2021: where do we stand?
Publication history
- Received April 23, 2021
- Accepted August 16, 2021
- First published August 25, 2021.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.